- DocumentJDRF Therapeutic Venturesuploaded bysstrumello7395
- DocumentGeneral Foods Corporate Timelineuploaded bysstrumello7395
- DocumentJDRF, Less Until Noneuploaded bysstrumello7395
- DocumentWhy Big Pharmaceutical Companies’ Current Nanotech Efforts Should Failuploaded bysstrumello7395
- DocumentNovo Nordisk Congressional Testimony on Follow-On Biopharmaceuticals Mollerup March 26, 2007uploaded bysstrumello7395
- DocumentEmblem Insulin Formulary Change 2010uploaded bysstrumello7395
- DocumentWhy Nonprofits Fund For-Profit Companies Doing Drug Researchuploaded bysstrumello7395
- DocumentAgaMatrix & Sanofi-Aventis Enter Global Diabetes Partnershipuploaded bysstrumello7395
- DocumentHuman insulin prepared by recombinant DNA techniques and native human insulin interact identically with insulin receptorsuploaded bysstrumello7395
- DocumentFDA ISO Standards for BG Meters 06-24-2009uploaded bysstrumello7395
- DocumentBeyond 'I'm a Diabetic', Little Common Grounduploaded bysstrumello7395
- DocumentHalozyme Therapeutics, Inc. 2009 Investor Day Presentationuploaded bysstrumello7395
- DocumentJDRF Countdown July 2009uploaded bysstrumello7395
- Document2008-03-24_Asset_EN Paper on Follow-On Biologics Jan. 2007uploaded bysstrumello7395
- Document2008-03-24_Asset_PCMA Summary of en Studyuploaded bysstrumello7395
- DocumentInfluence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabeticsuploaded bysstrumello7395
- DocumentThe Unique Cytoarchitechture of Human Pancreatic Islets Has Implications for Islet Cell Functionuploaded bysstrumello7395
- DocumentStatement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings on "Follow-On Biopharmaceuticals"uploaded bysstrumello7395
- DocumentMost Commercial Insulin Assays Fail to Detect Recombinant Insulin Analoguesuploaded bysstrumello7395
- DocumentHow Do We Define Cure of Diabetes?uploaded bysstrumello7395
- DocumentExpanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin isotopeuploaded bysstrumello7395
- DocumentCould Generic Insulin Soon Hit the U.S. Market?uploaded bysstrumello7395
- DocumentClass Action Complaint for Negligence, Products Liability and Punitive Damages Against Eli Lilly & Company and Novo Nordisk A/S Re; Biosynthetic Human Insulinuploaded bysstrumello7395
- DocumentMandated Diabetes Registries Will Not Benefit Persons With Diabetesuploaded bysstrumello7395
- DocumentDetermination of Purity and Identification of Animal Sources of Insulin in Various Insulin Preparationsuploaded bysstrumello7395
- DocumentPeter Van Etten JDRF Letter Reuploaded bysstrumello7395
- DocumentTreatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 yearsuploaded bysstrumello7395
- DocumentDifferent Potencies of Biosynthetic Human and Purified Porcine Insulinuploaded bysstrumello7395
- DocumentQuestions Answers &uploaded bysstrumello7395
- DocumentStem Cells and Diabetesuploaded bysstrumello7395
- DocumentFederal Funding of Stem Cell Researchuploaded bysstrumello7395